Parmax Pharma Limited (BOM:540359)
137.75
-1.35 (-0.97%)
At close: Oct 12, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 947.57 million as of October 16, 2026. It is the 41,565th most valuable company in the world and the 3,389th biggest in India. Its market cap has increased by 704.04% in one year.
Market Cap
947.57M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#3,389 India
PE Ratio
n/a
ChartMarket Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 947.57M, an increase of 1,295.44%. That is a compound annual growth rate of 44.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 947.57M | 648.66% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aayush Wellness | 1.23B |
| Makers Laboratories | 1.22B |
| Asston Pharmaceuticals | 1.17B |
| Pharmaids Pharmaceuticals | 1.06B |
| Mercury Laboratories | 906.00M |
| Concord Drugs | 901.17M |
| Amwill Health Care | 862.96M |
| Denis Chem Lab | 860.35M |